ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $832,000 | -2.2% | 21,347 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $851,000 | +10.4% | 21,347 | 0.0% | 0.01% | +200.0% |
| Q3 2021 | $771,000 | -11.9% | 21,347 | 0.0% | 0.00% | -40.0% |
| Q2 2021 | $875,000 | -59.9% | 21,347 | -57.3% | 0.01% | -58.3% |
| Q1 2021 | $2,181,000 | -24.9% | 50,000 | -13.8% | 0.01% | -45.5% |
| Q4 2020 | $2,903,000 | +38.0% | 58,000 | +16.0% | 0.02% | -12.0% |
| Q3 2020 | $2,104,000 | -13.3% | 50,000 | 0.0% | 0.02% | -7.4% |
| Q2 2020 | $2,428,000 | – | 50,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |